McAleavey, P. G., Walls, G. M. and Chalmers, A. J. (2022) Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review. CNS Oncology, 11(2), CNS86. (doi: 10.2217/cns-2021-0015) (PMID:35603818) (PMCID:PMC9134931)
Text
271569.pdf - Published Version Available under License Creative Commons Attribution. 847kB |
Abstract
Glioblastoma (GBM) accounts for over 50% of gliomas and carries the worst prognosis of all solid tumors. Owing to the limited local control afforded by surgery alone, efficacious adjuvant treatments such as radiotherapy (RT) and chemotherapy are fundamental in achieving durable disease control. The best clinical outcomes are achieved with tri-modality treatment consisting of surgery, RT and systemic therapy. While RT-chemotherapy combination regimens are well established in oncology, this approach was largely unsuccessful in GBM until the introduction of temozolomide. The success of this combination has stimulated the search for other candidate drugs for concomitant use with RT in GBM. This review seeks to collate the current evidence for these agents and synthesize possible future directions for the field.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Chalmers, Professor Anthony |
Authors: | McAleavey, P. G., Walls, G. M., and Chalmers, A. J. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | CNS Oncology |
Publisher: | Future Medicine |
ISSN: | 2045-0907 |
ISSN (Online): | 2045-0915 |
Published Online: | 23 May 2022 |
Copyright Holders: | Copyright © 2022 Patrick G McAleavey |
First Published: | First published in CNS Oncology 11(2):CNS86 |
Publisher Policy: | Reproduced under a Creative Commons license |
University Staff: Request a correction | Enlighten Editors: Update this record